Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
NMTC Stock Forecast 2026-2027
$2.51
Current Price
$21.15M
Market Cap
Buy 3
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to NMTC Price Targets
+417.9%
To High Target of $13.00
+250.6%
To Median Target of $8.80
+218.7%
To Low Target of $8.00
NMTC Price Momentum
-8.7%
1 Week Change
-22.8%
1 Month Change
-42.2%
1 Year Change
-44.8%
Year-to-Date Change
-63.9%
From 52W High of $6.96
+4.6%
From 52W Low of $2.40
📊 TOP ANALYST CALLS
Did NMTC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if NeuroOne is one of their latest high-conviction picks.
Latest NMTC Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, NMTC has a bullish consensus with a median price target of $8.80 (ranging from $8.00 to $13.00). The overall analyst rating is Strong Buy (9.3/10). Currently trading at $2.51, the median forecast implies a 250.6% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Jeff Cohen at Ladenburg Thalmann, suggesting a 218.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NMTC Analyst Ratings
3
Buy
0
Hold
0
Sell
NMTC Price Target Range
Low
$8.00
Average
$8.80
High
$13.00
Current: $2.51
Latest NMTC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NMTC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 13, 2026 | Ladenburg Thalmann | Jeff Cohen | Buy | Maintains | $8.00 |
| Mar 2, 2026 | Jones Trading | Buy | Initiates | $N/A | |
| Sep 9, 2025 | Maxim Group | Buy | Initiates | $N/A | |
| May 5, 2025 | Ladenburg Thalmann | Buy | Initiates | $N/A | |
| Aug 15, 2023 | Alliance Global Partners | Buy | Maintains | $N/A | |
| Mar 28, 2022 | Craig-Hallum | Hold | Downgrade | $N/A | |
| Dec 3, 2021 | Alliance Global Partners | Buy | Initiates | $N/A | |
| Nov 15, 2021 | Craig-Hallum | Buy | Initiates | $N/A |
NeuroOne Medical Technologies Corporation (NMTC) Competitors
The following stocks are similar to NeuroOne based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
NeuroOne Medical Technologies Corporation (NMTC) Financial Data
NeuroOne Medical Technologies Corporation has a market capitalization of $21.15M with a P/E ratio of -4.6x. The company generates $12.72M in trailing twelve-month revenue with a -52.2% profit margin.
Revenue growth is +72.5% quarter-over-quarter, while maintaining an operating margin of -87.9% and return on equity of -204.4%.
Valuation Metrics
Market Cap
$21.15M
Enterprise Value
$20.33M
P/E Ratio
-4.6x
PEG Ratio
0.1x
Price/Sales
1.8x
Growth & Margins
Revenue Growth (YoY)
+72.5%
Gross Margin
+53.2%
Operating Margin
-87.9%
Net Margin
-52.2%
EPS Growth
+34.3%
Financial Health
Cash/Price Ratio
+12.9%
Current Ratio
4.4x
Debt/Equity
3.9x
ROE
-204.4%
ROA
-71.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
NeuroOne Medical Technologies Corporation (NMTC) Business Model
About NeuroOne Medical Technologies Corporation
What They Do
Develops advanced neural surgical solutions.
Business Model
The company designs and markets electrode technology for brain activity recording and stimulation, generating revenue through the sale of these products to healthcare providers in the neurology and neurosurgery sectors.
Additional Information
NeuroOne aims to address unmet medical needs by offering less invasive and cost-effective solutions for brain surgeries and therapeutic treatments, positioning itself as a leader in the evolving field of neural technologies.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
18
CEO
Mr. David A. Rosa M.D.
Country
United States
IPO Year
2017
Website
nmtc1.comNeuroOne Medical Technologies Corporation (NMTC) Latest News & Analysis
Latest News
Quick Summary
NeuroOne Medical Technologies Corporation (NMTC) held its Q2 2026 earnings call, discussing financial performance and company developments. Further financial details were provided during the call.
Why It Matters
NeuroOne's Q2 2026 earnings call provides insights into financial performance, growth potential, and strategic direction, which can influence investment decisions and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
NeuroOne Medical Technologies Corporation (NMTC) outlined advancements in its platform technology and discussed growth strategies for neurological device applications.
Why It Matters
Advancements in NeuroOne's technology and growth plans signal potential for increased market penetration and revenue, impacting stock performance and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
NeuroOne Medical Technologies Corporation (NMTC) has released its Q1 2026 earnings call transcript, detailing its financial performance and business updates for the quarter.
Why It Matters
NMTC's Q1 2026 earnings call provides insights into financial performance, growth prospects, and strategic direction, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
New Strong Buy Stocks for January 6th
6 months ago
Quick Summary
ILPT, NMTC, RIGL, RIO, and BHP were added to the Zacks Rank #1 (Strong Buy) List on January 6, 2026, indicating a favorable outlook for these stocks.
Why It Matters
ILPT, NMTC, RIGL, RIO, and BHP receiving a Zacks Rank #1 indicates strong buy potential, signaling positive outlooks that may attract investor interest and drive stock prices higher.
Source: Zacks Investment Research
Market Sentiment:
Positive
Best Momentum Stocks to Buy for January 6th
6 months ago
Quick Summary
RIGL, CM, and NMTC are ranked #1 (Strong Buy) by Zacks as of January 6, 2026, indicating strong momentum for these stocks.
Why It Matters
RIGL, CM, and NMTC being ranked as Strong Buy indicates strong potential for price appreciation, suggesting bullish sentiment that could attract investor interest and trading activity.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
NeuroOne Medical Technologies Corporation (NMTC) held its Q4 2025 earnings call, discussing financial performance and business updates. Further details can be found in the full transcript.
Why It Matters
The earnings call provides insights into NMTC's financial performance and future outlook, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About NMTC Stock
What is NeuroOne Medical Technologies Corporation's (NMTC) stock forecast for 2027?
Based on our analysis of 2 Wall Street analysts, NeuroOne Medical Technologies Corporation (NMTC) has a median price target of $8.80. The highest price target is $13.00 and the lowest is $8.00.
Is NMTC stock a good investment in 2027?
According to current analyst ratings, NMTC has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.51. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NMTC stock?
Wall Street analysts predict NMTC stock could reach $8.80 in the next 12 months. This represents a 250.6% increase from the current price of $2.51. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is NeuroOne Medical Technologies Corporation's business model?
The company designs and markets electrode technology for brain activity recording and stimulation, generating revenue through the sale of these products to healthcare providers in the neurology and neurosurgery sectors.
What is the highest forecasted price for NMTC NeuroOne Medical Technologies Corporation?
The highest price target for NMTC is $13.00 from at , which represents a 417.9% increase from the current price of $2.51.
What is the lowest forecasted price for NMTC NeuroOne Medical Technologies Corporation?
The lowest price target for NMTC is $8.00 from Jeff Cohen at Ladenburg Thalmann, which represents a 218.7% increase from the current price of $2.51.
What is the overall NMTC consensus from analysts for NeuroOne Medical Technologies Corporation?
The overall analyst consensus for NMTC is bullish. Out of 2 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $8.80.
How accurate are NMTC stock price projections?
Stock price projections, including those for NeuroOne Medical Technologies Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 16, 2026 11:02 AM UTC